{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:13:49Z","timestamp":1778512429978,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EEQ12019\/000153"],"award-info":[{"award-number":["EEQ12019\/000153"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SB\/YS\/LS-123\/2014"],"award-info":[{"award-number":["SB\/YS\/LS-123\/2014"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["BT\/INF\/22\/SP45088 \/2022"],"award-info":[{"award-number":["BT\/INF\/22\/SP45088 \/2022"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["NCD\/Adhoc\/222\/2022-23"],"award-info":[{"award-number":["NCD\/Adhoc\/222\/2022-23"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.exphem.2025.105330","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T07:46:26Z","timestamp":1764315986000},"page":"105330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ERK-mTOR crosstalk suppresses autophagy and upregulates proteasomal degradation pathway to confer chronic myeloid leukemia cells resistant to imatinib"],"prefix":"10.1016","volume":"154","author":[{"given":"Rajdeep","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamalika","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritam Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samraj","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhartha Sankar","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maitreyee","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabendu","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2025.105330_bib0001","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.tplants.2023.01.013","article-title":"Interplay between autophagy and proteasome during protein turnover","volume":"28","author":"Raffeiner","year":"2023","journal-title":"Trends Plant Sci"},{"key":"10.1016\/j.exphem.2025.105330_bib0002","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10555-017-9705-x","article-title":"Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing","volume":"36","author":"Soave","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.exphem.2025.105330_bib0003","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.exphem.2025.105330_bib0004","doi-asserted-by":"crossref","unstructured":"(2020) Annex I. Yearb Int Trib Law Sea \/Annu Trib Int du droit la mer, Vol 23 193\u2013214. https:\/\/doi.org\/10.1163\/9789004443310_012","DOI":"10.1163\/9789004443310_012"},{"key":"10.1016\/j.exphem.2025.105330_bib0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.exphem.2025.105330_bib0006","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2025.105330_bib0007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41576-020-00299-4","article-title":"Mutation-selection balance and compensatory mechanisms in tumour evolution","volume":"22","author":"Persi","year":"2021","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.exphem.2025.105330_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.11.005","article-title":"Resistance to epigenetic-targeted therapy engenders tumor cell vulnerabilities associated with enhancer remodeling","volume":"34","author":"Iniguez","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2025.105330_bib0009","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","article-title":"Paz-Ares L. Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors","volume":"29","author":"Westover","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.exphem.2025.105330_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100720","article-title":"Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification","volume":"53","author":"Li","year":"2020","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.exphem.2025.105330_bib0011","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41588-020-0648-8","article-title":"The DNA methylation landscape of advanced prostate cancer","volume":"52","author":"Zhao","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2025.105330_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100796","article-title":"Anticancer drug resistance: an update and perspective","volume":"59","author":"Nussinov","year":"2021","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.exphem.2025.105330_bib0013","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1073\/pnas.1814742116","article-title":"MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer","volume":"116","author":"Wu","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2025.105330_bib0014","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10495-017-1375-1","article-title":"Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)","volume":"22","author":"Rathore","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.exphem.2025.105330_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1562167","article-title":"Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers","volume":"16","author":"Ye","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.exphem.2025.105330_bib0016","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/cas.15068","article-title":"Reactive oxygen species in cancer: current findings and future directions","volume":"112","author":"Nakamura","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.exphem.2025.105330_bib0017","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/biom9110735","article-title":"Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements","volume":"9","author":"Aggarwal","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.exphem.2025.105330_bib0018","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/CAD.0000000000000710","article-title":"Hydroxychavicol sensitizes imatinib-resistant chronic myelogenous leukemia cells to TRAIL-induced apoptosis by ROS-mediated IAP downregulation","volume":"30","author":"Paul","year":"2019","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.exphem.2025.105330_bib0019","doi-asserted-by":"crossref","first-page":"8311","DOI":"10.1039\/D4SC01294A","article-title":"Clinically used drug arsenic trioxide targets XIAP and overcomes apoptosis resistance in an organoid-based preclinical cancer model","volume":"15","author":"Shi","year":"2024","journal-title":"Chem Sci"},{"key":"10.1016\/j.exphem.2025.105330_bib0020","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3390\/cancers13112807","article-title":"Expression of X-linked inhibitor of apoptosis protein (XIAP) in breast cancer is associated with shorter survival and resistance to chemotherapy","volume":"13","author":"Devi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2025.105330_bib0021","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.1158\/0008-5472.CAN-08-1296","article-title":"Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo","volume":"68","author":"Vogler","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2025.105330_bib0022","article-title":"AP-1 confers resistance to anti-cancer therapy by activating XIAP","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.exphem.2025.105330_bib0023","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.biopha.2018.08.065","article-title":"The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in leukemia","volume":"107","author":"Saraei","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.exphem.2025.105330_bib0024","doi-asserted-by":"crossref","first-page":"11985","DOI":"10.1007\/s13277-014-2497-5","article-title":"20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K\/Akt and XIAP pathways","volume":"35","author":"Wang","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.exphem.2025.105330_bib0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.freeradbiomed.2021.02.024","article-title":"H2O2 mediated FLIP and XIAP down-regulation involves increased ITCH expression and ERK-Akt crosstalk in imatinib resistant chronic myeloid leukemia cell line K562","volume":"166","author":"Paul","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.exphem.2025.105330_bib0026","unstructured":"TNMplot. https:\/\/tnmplot.com\/analysis\/. Accessed 30 Mar 2025"},{"key":"10.1016\/j.exphem.2025.105330_bib0027","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.febslet.2009.12.047","article-title":"Rubinsztein DC. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems","volume":"584","author":"Korolchuk","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.exphem.2025.105330_bib0028","doi-asserted-by":"crossref","first-page":"36611","DOI":"10.1074\/jbc.M200317200","article-title":"Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro","volume":"277","author":"MacFarlane","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2025.105330_bib0029","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13045-020-01000-2","article-title":"Targeting autophagy to overcome drug resistance: further developments","volume":"13","author":"Chang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2025.105330_bib0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/ijms22010179","article-title":"The dual role of autophagy in cancer development and a therapeutic strategy for cancer by targeting autophagy","volume":"22","author":"Yun","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.exphem.2025.105330_bib0031","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12032-024-02417-2","article-title":"Dissecting the multifaceted roles of autophagy in cancer initiation, growth, and metastasis: from molecular mechanisms to therapeutic applications","volume":"41","author":"Ayub","year":"2024","journal-title":"Med Oncol"},{"key":"10.1016\/j.exphem.2025.105330_bib0032","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3892\/mco.2022.2505","article-title":"Role of autophagy in drug resistance and regulation of osteosarcoma","volume":"16","author":"Pu","year":"2022","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.exphem.2025.105330_bib0033","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1038\/s41598-022-09763-z","article-title":"Prolonged treatment with the proteasome inhibitor MG-132 induces apoptosis in PC12 rat pheochromocytoma cells","volume":"12","author":"Tarj\u00e1nyi","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2025.105330_bib0034","first-page":"3509","article-title":"Autophagy inhibitor chloroquine induces apoptosis of cholangiocarcinoma cells via endoplasmic reticulum stress","volume":"16","author":"Jia","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.exphem.2025.105330_bib0035","doi-asserted-by":"crossref","first-page":"C166","DOI":"10.1152\/ajpcell.00074.2016","article-title":"It\u2019s all about talking: Two-way communication between proteasomal and lysosomal degradation pathways via ubiquitin","volume":"311","author":"Liebl","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.exphem.2025.105330_bib0036","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1074\/jbc.M312044200","article-title":"Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP)","volume":"279","author":"Dan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2025.105330_bib0037","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3892\/etm.2014.1684","article-title":"JNK inhibitor SP600125 protects against lipopolysaccharide-induced acute lung injury via upregulation of claudin-4","volume":"8","author":"Zheng","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.exphem.2025.105330_bib0038","first-page":"9644","article-title":"Inhibitory effect of the mitogen activated protein kinase specific inhibitor PD98059 on Mtb-Ag-activated \u03b3\u03b4\u03a4 cells","volume":"10","author":"Wang","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.exphem.2025.105330_bib0039","doi-asserted-by":"crossref","first-page":"253","DOI":"10.15616\/BSL.2018.24.3.253","article-title":"Inhibitory effects of PD98059, SB203580, and SP600125 on \u03b1- and \u03b4-granule release and intracellular Ca2+ levels in human platelets","volume":"24","author":"Kwon","year":"2018","journal-title":"Biomed Sci Lett"},{"key":"10.1016\/j.exphem.2025.105330_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081162","article-title":"Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions","volume":"8","author":"Marullo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2025.105330_bib0041","doi-asserted-by":"crossref","first-page":"374","DOI":"10.7150\/ijbs.66602","article-title":"Enhanced intracellular reactive oxygen specie by photodynamic therapy effectively promotes chemoresistant cell death","volume":"18","author":"Xu","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.exphem.2025.105330_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108292","article-title":"Guanylate-binding protein 1 modulates proteasomal machinery in ovarian cancer","volume":"26","author":"Tailor","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.exphem.2025.105330_bib0043","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6650045","article-title":"F1012-2 Induced ROS-mediated DNA damage response through activation of MAPK pathway in triple-negative breast cancer","volume":"2021","author":"Dai","year":"2021","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.exphem.2025.105330_bib0044","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s43018-024-00738-9","article-title":"The pleiotropic functions of reactive oxygen species in cancer","volume":"5","author":"Wu","year":"2024","journal-title":"Nat Cancer"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25006198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25006198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:45:04Z","timestamp":1778510704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X25006198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":44,"alternative-id":["S0301472X25006198"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2025.105330","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ERK-mTOR crosstalk suppresses autophagy and upregulates proteasomal degradation pathway to confer chronic myeloid leukemia cells resistant to imatinib","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2025.105330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105330"}}